Clinical trial
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05094154 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 10, 2021
- Completion date
- October 21, 2022
- Enrollment
- 2,634 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aki, neurotoxicity, sepsis